Dr. Lal PathLabs’ arm gets nod for signing binding term sheet

01 Oct 2019 Evaluate

Dr. Lal PathLabs’ wholly owned subsidiary -- Pathlabs Unifiers has received approval for signing binding term sheet for acquisition of 70% equity stake in a ‘New Company to be incorporated’. The Board of Director of Pathlabs Unifiers at their meeting held on October 01, 2019, approved the same.

According to the Term Sheet, the ‘New Company to be incorporated’ will house the business of Amins Pathology Referral Laboratory, a Proprietorship concern of Dr. Ripal Padmani and engaged in Pathology Business in Vadodara in Gujarat, before Pathlabs Unifiers buys 70% stake in it.

Dr. Lal Pathlabs is recognized as a centre of innovation and a premier clinical pathology laboratory. It is the largest and most respected diagnostic service provider in the country.

Dr. Lal Pathlabs Share Price

1382.30 -15.35 (-1.10%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7128.20
Max Healthcare Inst 1012.85
Narayana Hrudayalay 1861.10
Aster DM Healthcare 573.90
Global Health 1114.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×